Switch to: References

Add citations

You must login to add citations.
  1. Anticipatory Ethics and Governance : Towards a Future Care Orientation Around Nanotechnology.Syed A. M. Tofail, Finbarr Murphy, Martin Mullins & Karena Hester - 2015 - NanoEthics 9 (2):123-136.
    Nanotechnology presents significant challenges in terms of developing a regulatory framework. This is due to a lack of scientific knowledge about the behaviour of the technology in its interactions with biological and ecological processes, the environment and other technologies. Crucially, there is a great deal of uncertainty surrounding the potential environmental and human health and safety impacts of NT. Consequently, the development of NT is a potential test case for framing new models of ‘soft law’ voluntary governance as a substitute (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  • Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
    Clinical trials of nanotechnology medical products present complex risk management challenges that involve many uncertainties and important risk-risk trade-offs. This paper inquires whether the precautionary principle can help to inform risk management approaches to nanomedicine clinical trials. It concludes that prudent precaution may be appropriate for ensuring the safety of such trials, but that the precautionary principle itself, especially in its more extreme forms, does not provide useful guidance for specific safety measures.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
    Medical technologies, including nanomedicine products, are intended to improve health but in many cases may also create their own health risks. Medical products that create their own health risks differ from most other risk-creating technologies in that the very purpose of the medical technology is to prevent or treat health risks. This paradox of technologies intended to reduce existing risks that may have the effect of creating new risks has two conflicting implications. On one hand, we may be more tolerant (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • More than a Decade On: Mapping Today’s Regulatory and Policy Landscapes Following the Publication of Nanoscience and Nanotechnologies: Opportunities and Uncertainties.Diana M. Bowman - 2017 - NanoEthics 11 (2):169-186.
    It is now more than a decade since the release of the Royal Society and Royal Academy of Engineering’s seminal report on nanosciences and nanotechnologies. The report, for the first time, brought together the spectrum of scientific and societal issues underpinning the emergence of the technology. In articulating 21 recommendations, the RA/RAEng provided the United Kingdom Government—and others—with an agenda on how they could, and should, deal with the disparate aspects of the technology. The report provides a baseline to measure (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation